Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00523133 · ClinicalTrials.gov registry record · Phase 2
Research on Individualized Treatment for Alcoholism
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
- 185
- Enrollment target
NCT00523133 is a Phase 2 study that has completed, run by Indiana University. The registered enrollment target is 185 participants.
The verdict
NCT00523133, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 185 participants
- Enrollment target
Study Summary
The purpose of this study was to compare the effects of two psychosocial treatments that differed in scope and intensity (Broad Spectrum Treatment and Motivational Enhancement Treatment) combined with 3 or 6 months of treatment with naltrexone on alcohol drinking behaviors in alcohol dependent patients.
Interventions
- DRUG naltrexone
- BEHAVIORAL Broad Spectrum Treatment
- BEHAVIORAL Motivational Enhancement Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00523133
The ClinicalTrials.gov registry entry for NCT00523133 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which naltrexone is the first listed.
NCT00523133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00523133 about?
NCT00523133 is a clinical study titled "Research on Individualized Treatment for Alcoholism". The purpose of this study was to compare the effects of two psychosocial treatments that differed in scope and intensity (Broad Spectrum Treatment and Motivational Enhancement Treatment) combined with 3 or 6 months of treatment with naltrexone on alcohol drinking behaviors in alcohol dependent patie...
What is the current status of trial NCT00523133?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 185 participants. The study started on 2000-09. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00523133?
The interventions under investigation include: naltrexone (DRUG), Broad Spectrum Treatment (BEHAVIORAL), Motivational Enhancement Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00523133?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.